Predictive testing in contact allergy: Facts and future

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 10, 2001, Pages 937-943

  Basketter, D A ^a   Kimber, I ^b  

^a UNILEVER RESEARCH   (United Kingdom)

^b JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

CONTACT ALLERGY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOBIOLOGY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; SKIN SENSITIZATION;

ALLERGENS; ANIMALS; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; GUINEA PIGS; LOCAL LYMPH NODE ASSAY; MICE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SKIN TESTS;

EID: 0034853180     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00147.x     Document Type: Review

References (83)

1. Guinea pig sensitization assays: An overview
2. Skin sensitization - A critical review of predictive test methods in animal and man
3. The identification of contact allergens by animal assay. The guinea pig maximization test
4. Testing for skin sensitisation according to the notification procedure for new chemicals: The Magnusson and Kligman test
5. Contact and respiratory allergy: A regulatory perspective
6. Sulphanilic acid: Divergent results in the guinea pig maximization test and the local lymph node assay
7. Nonspecific hypersensitivity: False-positive responses with the use of Freund's complete adjuvant
8. A critical commentary and updating of the guinea pig maximisation test
9. The value and limitations of rechallenge in the guinea pig maximisation test
10. Delayed contact hypersensitivity in the guinea pig
11. A review of the Buehler guinea pig skin sensitisation test and its use in a risk assessment process for human skin sensitization
12. Identification of contact allergens using the murine local lymph node assay: Comparisons with the Buehler occluded patch test in guinea pigs
13. Interlaboratory evaluation of the Buehler test
14. Local lymph node assay validation assessment for regulatory purposes
15. The local lymph node assay: Further comparisons with guinea pig and human sensitization data
16. Guinea pig predictive test for contact hypersensitivity
17. The identification of contact allergens by human assay. II. Factors influencing the induction and measurement of allergic contact dermatitis
18. Contact sensitivity and bioavailability of chlorocresol
19. The identification of contact allergens by human assay I
20. The identification of contact allergens by human assay. III. The maximization test: A procedure for screening and rating contact sensitisers
21. Antimicrobials: Experimental contact sensitization in man
22. The use of graded concentrations in studying skin sensitization: Experimental contact sensitization in man
23. Performance of the local lymph node assay with chemicals identified as contact allergens in the human maximisation test
24. Predictive tests for irritants and allergens and their use in quantitative risk assessment
25. Skin sensitization: Risk assessment
26. The Freund's complete adjuvant test and the open epicutaneous test
27. The guinea pig maximization test with a multiple dose design
28. Skin sensitisation testing in potency and risk assessment
29. Statement on the validity of the local lymph node assay for skin sensitisation testing
30. Temporal stability of local lymph node assay responses to hexyl cinnamic aldehyde
31. Induction of formaldehyde contact sensitivity and dose response relationship in the guinea pig maximisation test
32. Immune responses to contact allergens and novel approaches to hazard evaluation
33. Approaches for the development of cell based in vitro methods for contact sensitization
34. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin
35. Modulation of cytokine message in the epiderm in vitro skin model following treatment with contact allergens and skin irritants
36. Selective induction of cell-associated interleukin-1α in murine keratinocytes by chemical allergens
37. Allergens and irritants transcriptionally upregulate CD80 gene expression in human keratinocytes
38. Tolerance, danger and the extended family
39. Contact allergy, irritancy and danger
40. Novel predictive assay for contact allergens using human skin explant cultures
41. Langerhans cell migration
42. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules
43. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals
44. Simple chemicals can induce maturation and apoptosis of dendritic cells
45. Cytokine gene expression in murine epidermal cell suspensions: Interleukin 1β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture
46. Langerhans cells are the major source of mRNA for IL-1β and MIP-1α among unstimulated murine epidermal cells
47. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration
48. Langerhans cell migration in mice requires intact type 1 interleukin 1 receptor (IL-1RI) function
49. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in the skin
50. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene
51. Early molecular events in the induction phase of contact sensitivity
52. Alternative methods for skin sensitisation testing. The report and recommendations of ECVAM workshop 19
53. Human and murine dendritic cells. Isolation by means of a novel method and phenotypical and functional characterisations
54. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α
55. In vitro model for contact sensitization. II. Induction of IL-1β mRNA in human blood-derived dendritic cells by contact sensitizers
56. Investigation of induced changes in interleukin 1β expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing
57. Allergen induced changes in interleukin 1β (IL 1β) mRNA expression by human blood derived dendritic cells: Inter-individual differences and relevance for sensitization testing
58. Development of an expert system rulebase for identifying contact allergens
59. An expert system rulebase for identifying contact allergens
60. Computer prediction of possible toxic action from chemical structure: An update on the DEREK system
61. Validation and subsequent development of the DEREK skin sensitization rulebase by analysis of the BgVV list of contact allergens
62. Skin sensitisation structure activity relationships for aldehydes
63. Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitizing potential
64. Contact sensitization: A new approach to risk assessment
65. A comparison of statistical approaches to derivation of EC3 values from local lymph node assay dose responses
66. Temporal stability of local lymph node assay responses to hexyl cinnamic aldehyde
67. Local lymph node assay responses to paraphenylenediamine: Intra- and inter-laboratory evaluations
68. Estimation of relative skin sensitizing potency using the local lymph node assay: A comparison of formaldehyde and glutaraldehyde
69. Skin sensitization risk assessment: A comparative evaluation of three isothiazolinone biocides
70. Use of the local lymph node assay for the estimation of relative contact allergenic potency
71. Contact allergenic potency: Correlation of human and local lymph node assay data
72. Human potency predictions for aldehydes using the local lymph node assay
73. The importance of exposure estimation in the assessment of skin sensitization risk
74. Dangerous substances directive, 22nd adaptation to technical progress (96/54/EC)
75. Understanding fragrance allergy using an exposure-based risk assessment approach